Asia Pacific Protein Therapeutics Market By Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Application (Metabolic Disorders, Immunologic Disorders, Haematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others), By Therapeutic Modalities (Protein Diagnostics, Protein Vaccines, Protein Therapeutics With Special Targeting Activity, Protein Therapeutics With Enzymatic Or Regulatory Activity), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

Asia Pacific Protein Therapeutics Market By Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Application (Metabolic Disorders, Immunologic Disorders, Haematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others), By Therapeutic Modalities (Protein Diagnostics, Protein Vaccines, Protein Therapeutics With Special Targeting Activity, Protein Therapeutics With Enzymatic Or Regulatory Activity), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

ID: 5249 | Pages: 145 | December 2017 | Region: Asia Pacific


The Asia Pacific Protein Therapeutics market size was around USD 28.2 billion in 2017. It is expected to grow at a CAGR of 7.3% to reach USD 40.11 billion by 2022. It captures 20% of the global market.

Protein therapeutics is most often employed in the treatment of chronic ailments like cancer etc. This market has a huge potential in the coming years.

Increasing number of people suffering from chronic diseases coupled with rapid advancements in the medical sciences resulting in the development of plasma based therapies are driving the growth of this market.

On the other hand, vague government policies and cumbersome administrative framework conjoined with the heavy cost of this treatment are inhibiting market growth.

The market has been segregated into three categories namely - by product, by application and by therapeutic modalities. Classification by product entails Interferon, Human Growth Hormone, Insulin, Fusion Protein, Follicle Stimulating Hormone, and Monoclonal Antibodies, Erythropoietin. In 2016, Monoclonal antibodies captured the largest market share. It is projected to remain the top leading segment in the forecast period. It is also the market sub-segment which is anticipated to undergo fastest growth till 2022. Classification by application entails Cancer, Hormonal Disorders, Immunologic Disorders, Haematological Disorders, Metabolic Disorders, Genetic Disorders, and Others. In 2016, metabolic disorders accounted for the highest market share. However, cancer market sub-category is predicted to grow the fastest in the forecast period. Classification by therapeutic modalities entails Protein therapeutics with special targeting activity, Protein diagnostics, Protein vaccines, and Protein therapeutics with enzymatic or regulatory activity.

Classification by geography entails India, China, Korea, Japan and others. However, growing awareness about these novel treatment methods in the emerging economies makes it likely that Asia Pacific will grow with the highest CAGR in the forecast period. China leads the market in this region.

Key players in the market are Baxter International Inc., Eli Lilly and Company, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche Ltd. Other players in the market are Novo Nordisk A/S, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., and Sanofi.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Product                       

                              5.1.1 Introduction           

                              5.1.2 Monoclonal Antibodies      

                              5.1.3 Insulin       

                              5.1.4 Fusion Protein       

                              5.1.5 Erythropoietin       

                              5.1.6 Interferon

                              5.1.7 Human Growth Hormone  

                              5.1.8 Follicle Stimulating Hormone          

                              5.1.9 Y-o-Y Growth Analysis, By Product

                              5.1.10 Market Attractiveness Analysis, By Product           

                              5.1.11 Market Share Analysis, By Product            

               5.2 Therapeutic Modalities                         

                              5.2.1 Introduction           

                              5.2.2 Protein diagnostics             

                              5.2.3 Protein vaccines   

                              5.2.4 Protein therapeutics with special targeting activity

                              5.2.5 Protein therapeutics with enzymatic or regulatory activity 

                              5.2.6 Y-o-Y Growth Analysis, By Therapeutic Modalities  

                              5.2.7 Market Attractiveness Analysis, By Therapeutic Modalities

                              5.2.8 Market Share Analysis, By Therapeutic Modalities

               5.3 Application                 

                              5.3.1 Introduction           

                              5.3.2 Metabolic Disorders            

                              5.3.3 Immunologic Disorders      

                              5.3.4 Hematological Disorders    

                              5.3.5 Cancer      

                              5.3.6 Hormonal Disorders            

                              5.3.7 Genetic Disorders 

                              5.3.8 Others      

                              5.3.9 Y-o-Y Growth Analysis, By Application         

                              5.3.10 Market Attractiveness Analysis, By Application     

                              5.3.11 Market Share Analysis, By Application      

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Product

                                             6.1.3.3 By Therapeutic Modalities

                                             6.1.3.4 By Application

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Product

                                             6.1.4.3 By Therapeutic Modalities

                                             6.1.4.4 By Application

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Product

                                             6.1.5.3 By Therapeutic Modalities

                                             6.1.5.4 By Application

               6.2 China                           

               6.3 India                            

               6.4 Japan                           

               6.5 South Korea               

               6.6 Australia                     

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Abbott Laboratories               

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Amgen Inc.                

               8.3 Baxter International Inc.                      

               8.4 Eli Lilly and Company                            

               8.5 F. Hoffmann-La Roche Ltd.                  

               8.6 Johnson & Johnson                

               8.7 Merck & Co. Inc.                     

               8.8 Novo Nordisk A/S                    

               8.9 Pfizer Inc.                   

               8.10 Sanofi                       

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Protein Therapeutics Market By Product, From 2016-2022 ( USD Billion )
  2. Asia Pacific Monoclonal Antibodies Market By Region, From 2016-2022 ( USD Billion )
  3. Asia Pacific Insulin Market By Region, From 2016-2022 ( USD Billion )
  4. Asia Pacific Fusion Protein Market By Region, From 2016-2022 ( USD Billion )
  5. Asia Pacific Erythropoietin Market By Region, From 2016-2022 ( USD Billion )
  6. Asia Pacific Interferon Market By Region, From 2016-2022 ( USD Billion )
  7. Asia Pacific Human Growth Hormone Market By Region, From 2016-2022 ( USD Billion )
  8. Asia Pacific Follicle Stimulating Hormone Market By Region, From 2016-2022 ( USD Billion )
  9. Asia Pacific Protein Therapeutics Market By Application, From 2016-2022 ( USD Billion )
  10. Asia Pacific Metabolic Disorders Market By Region, From 2016-2022 ( USD Billion )
  11. Asia Pacific Immunologic Disorders Market By Region, From 2016-2022 ( USD Billion )
  12. Asia Pacific Hematological Disorders Market By Region, From 2016-2022 ( USD Billion )
  13. Asia Pacific Cancer Market By Region, From 2016-2022 ( USD Billion )
  14. Asia Pacific Hormonal Disorders Market By Region, From 2016-2022 ( USD Billion )
  15. Asia Pacific Genetic Disorders Market By Region, From 2016-2022 ( USD Billion )
  16. Asia Pacific Others Market By Region, From 2016-2022 ( USD Billion )
  17. Asia Pacific Protein Therapeutics Market By Therapeuctic Modalities, From 2016-2022 ( USD Billion )
  18. Asia Pacific Protein diagnostics Market By Region, From 2016-2022 ( USD Billion )
  19. Asia Pacific Protein vaccines Market By Region, From 2016-2022 ( USD Billion )
  20. Asia Pacific Protein therapeutics with special targeting activity Market By Region, From 2016-2022 ( USD Billion )
  21. Asia Pacific Protein therapeutics with enzymatic or regulatory activity Market By Region, From 2016-2022 ( USD Billion )
  22. Japan Protein Therapeutics Market By Product, From 2016-2022 ( USD Billion )
  23. Japan Protein Therapeutics Market By Application, From 2016-2022 ( USD Billion )
  24. Japan Protein Therapeutics Market By Therapeuctic Modalities, From 2016-2022 ( USD Billion )
  25. China Protein Therapeutics Market By Product, From 2016-2022 ( USD Billion )
  26. China Protein Therapeutics Market By Application, From 2016-2022 ( USD Billion )
  27. China Protein Therapeutics Market By Therapeuctic Modalities, From 2016-2022 ( USD Billion )
  28. India Protein Therapeutics Market By Product, From 2016-2022 ( USD Billion )
  29. India Protein Therapeutics Market By Application, From 2016-2022 ( USD Billion )
  30. India Protein Therapeutics Market By Therapeuctic Modalities, From 2016-2022 ( USD Billion )
  31. Australia Protein Therapeutics Market By Product, From 2016-2022 ( USD Billion )
  32. Australia Protein Therapeutics Market By Application, From 2016-2022 ( USD Billion )
  33. Australia Protein Therapeutics Market By Therapeuctic Modalities, From 2016-2022 ( USD Billion )
  34. South Korea Protein Therapeutics Market By Product, From 2016-2022 ( USD Billion )
  35. South Korea Protein Therapeutics Market By Application, From 2016-2022 ( USD Billion )
  36. South Korea Protein Therapeutics Market By Therapeuctic Modalities, From 2016-2022 ( USD Billion )
Middle East And Africa Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Gr...
Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Asia Pacific Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tren...
Europe Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, An...
North America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region Global (Industry Analysis, Size, Share, Growth, Trends, An...
Middle East And Africa Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022...
Latin America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Asia Pacific Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Europe Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
North America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.